Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silymarin CF is a high-potency topical antioxidant serum formulated specifically for oily and blemish-prone skin. Developed by SkinCeuticals, it features a synergistic combination of 0.5% silymarin (milk thistle extract), 15% L-ascorbic acid (pure Vitamin C), 0.5% ferulic acid, and 0.5% salicylic acid. The product is designed to provide environmental protection by neutralizing free radicals and, uniquely, by inhibiting the oxidation of sebum lipids—a process known as lipid peroxidation that is a key precursor to acne formation. In addition to preventing breakouts, the serum helps reduce oiliness, refine skin texture, and improve skin clarity and fine lines through its antioxidant and keratolytic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Silymarin CF.